Clay B. Siegall
3 stock trades in the last 12 months, shares they bought or sold themselves (not grants or options).
We do the work for you. Every stock is scored and ranked, every 15 seconds while the market is open. Here it's 15 minutes behind. Pro members see it live.
Every trade Clay B. Siegall reported
| Stock | Trade | Amount | Traded |
|---|---|---|---|
| Buy | $501K | Mar 27SEC filing | |
| Buy | $100K | Dec 30, 2025SEC filing | |
| Buy | $149K | Dec 19, 2025SEC filing |
We do the work for you. Every stock is scored and ranked, every 15 seconds while the market is open. Here it's 15 minutes behind. Pro members see it live.
Clay B. Siegall's companies
| Stock | Trades | Quality Score |
|---|---|---|
| 3 | ||
| 0 |
Alerts for Clay B. Siegall
Use this page
How to cite
Breakaway, Clay B. Siegall: President and CEO at Immunome (IMNM), Jul 23, 2026, getbreakaway.com/insiders/clay-b-siegall
Journalists: email support@getbreakaway.com for the data behind this page.